Guardant Shield Colorectal Cancer Screening
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The purpose of this research is to identify individuals overdue for colon cancer screening and send them a reminder to complete their screening, which includes standard of care colonoscopy or stool-based testing. The investigators are randomizing patients (like a flip of a coin) to either receive the standard reminder by mail/email or to receive the standard reminder and have the option to provide a blood sample for screening (ShieldTM by Guardant).
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Dorośli w wieku 45-85 lat o średnim ryzyku zachorowania
- •Osoby, które nie przeszły zaplanowanego badania przesiewowego (kolonoskopia lub test stolca)
✗ Disqualifies
- •Osoby z historią raka jelita grubego lub polipy jelita
- •Osoby z pozytywnym wynikiem badania przesiewowego w ostatnich 6 miesięcy
- •Osoby z zapaleniem jelit (zapalenie jelita grubego, choroba Crohna)
- •Osoby z rodzinną historią raka jelita grubego
- •Osoby z genetycznym predyspozycją do raka jelita (np. zespół Lyncha)
- •Osoby z objawami jak krwawienie z odbytu lub utrata wagi, u których kolonoskopia jest niezbędna
Simplified criteria — AI translation
Trial details
- Minimum age
- 45 Years
- Maximum age
- 85 Years
- Last updated (source)
- July 27, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (1)
University of Miami
Miami, United States
Trial contact
Helen Kattoura
Shria Kumar, MD, MSCE
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/28/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.